Terconazole
Azole Antifungal
NADAC/unit
$0.5629
No Shortage
Tier 1: 71.4%
3 Manufacturers
5 ANDAs
Terconazole treats fungal infections by inhibiting ergosterol synthesis in fungal cell membranes.
Market Intelligence
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
Generic Manufacturers
FOUGERA PHARMACEUTICALS INCPADAGIS ISRAEL PHARMACEUTICALS LTDSUN PHARMA CANADA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
